laxmikant ramprasad kabra's most recent trade in Eiko Lifesciences Ltd. was a Acquisition of 50,000 Equity Shares done at an average price of Rs. 45 . Disclosure was reported to the exchange on May 17, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
laxmikant ramprasad kabra's has made SAST transactions in Eiko Lifesciences Ltd. recently where a Acquisition of 50,000 shares done . Disclosure was reported to the exchange on May 17, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eiko Lifesciences | Laxmikant Ramprasad Kabra | Promoter | Acquisition | 18 May 2022 | 50,000 | 70,000 (0.84%) | 0.60% | - | 17 May 2022 17 May 2022 |
SAST (29(2)) | - | Off Market | |
| Eiko Lifesciences | Laxmikant Ramprasad Kabra | Promoter & Director | Acquisition | 17 May 2022 | 50,000 | 70,000 (0.84%) | 0.60% | 45 | 2,250,000 | 17 May 2022 17 May 2022 |
Insider Trading | Equity Shares | Off Market |